Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.AWHL · Entity 7871 | Director | December 02, 2025 | December 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date December 02, 2025 · Filed December 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.35 · Expires 2035-12-02 | Direct | 238,085 |
Reported balance
After 2025-12-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-02 · Grant · Acquired 238,085 · Balance 238,085 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2025 Filed Dec 4, 2025 14:05 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | GrantStock Option (Right to Buy) · Derivative | 238,085 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001493152-25-026119 · ownership.xml · derivative · entry 1 Hundorfean Cynthia D · CIK 0002065631 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,085 Underlying: Common Stock · 238,085 shares Expires 2035-12-02 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.